Page last updated: 2024-09-02

ecteinascidin 743 and rucaparib

ecteinascidin 743 has been researched along with rucaparib in 1 studies

Compound Research Comparison

Studies
(ecteinascidin 743)
Trials
(ecteinascidin 743)
Recent Studies (post-2010)
(ecteinascidin 743)
Studies
(rucaparib)
Trials
(rucaparib)
Recent Studies (post-2010) (rucaparib)
66010240423636220

Protein Interaction Comparison

ProteinTaxonomyecteinascidin 743 (IC50)rucaparib (IC50)
Poly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)0.0847
Poly [ADP-ribose] polymerase 1Homo sapiens (human)0.0418
Protein mono-ADP-ribosyltransferase PARP14Homo sapiens (human)8.8713
Protein mono-ADP-ribosyltransferase PARP10Homo sapiens (human)1.4333
Protein mono-ADP-ribosyltransferase PARP12Homo sapiens (human)6.6285
Poly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)0.4523
Poly [ADP-ribose] polymerase 2Homo sapiens (human)0.0497
Protein mono-ADP-ribosyltransferase PARP4Homo sapiens (human)0.8354
Protein mono-ADP-ribosyltransferase PARP3Homo sapiens (human)0.4597

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Algéo, MP; Chaire, V; Italiano, A; Laroche, A; Le Loarer, F; Lucchesi, C; Rey, C; Tran, K1

Other Studies

1 other study(ies) available for ecteinascidin 743 and rucaparib

ArticleYear
Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomas.
    Journal of hematology & oncology, 2017, 04-11, Volume: 10, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dioxoles; DNA Repair; Drug Synergism; Heterografts; Humans; Indoles; Mice; Poly(ADP-ribose) Polymerase Inhibitors; Sarcoma; Tetrahydroisoquinolines; Trabectedin

2017